Eagle Bay Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,655
Closed -$215K 119
2025
Q1
$215K Sell
2,655
-325
-11% -$29K 0.18% 102
2024
Q4
$268K Hold
2,980
0.17% 91
2024
Q3
$294K Hold
2,980
0.11% 132
2024
Q2
$276K Hold
2,980
0.17% 92
2024
Q1
$283K Buy
2,980
+43
+1% +$3.99K 0.18% 97
2023
Q4
$262K Hold
2,937
0.17% 99
2023
Q3
$214K Sell
2,937
-398
-12% -$31.8K 0.1% 139
2023
Q2
$277K Buy
3,335
+721
+28% +$60.3K 0.16% 94
2023
Q1
$199K Sell
2,614
-417
-14% -$34.6K 0.11% 127
2022
Q4
$252K Sell
3,031
-510
-14% -$41.3K 0.14% 108
2022
Q3
$281K Sell
3,541
-1,210
-25% -$102K 0.17% 90
2022
Q2
$353K Buy
4,751
+1,039
+28% +$78K 0.22% 77
2022
Q1
$334K Buy
3,712
+2,373
+177% +$219K 0.27% 72
2021
Q4
$288K Buy
+1,339
New +$161K 0.19% 81

Other funds holding XBI